Pharma Integrates Speakers 2020

JOHN TSAI

Head of Global Drug Development, Chief Medical Officer

Novartis

SIR MENELAS (MENE) PANGALOS

Executive Vice President, BioPharmaceuticals R&D

AstraZeneca

ANDREW PLUMP

President, Research & Development

Takeda Pharmaceutical Company

HUGO FRY

Managing Director | Vice President

Sanofi UK | ABPI

MARK STEVENSON

Executive Vice President and Chief Operating Officer

Thermo Fisher Scientific

MATTHEW CLEMENTE

Vice President, Device Development, Device R&D

Novo Nordisk

DAVE TUDOR

Managing Director, Medicines Manufacturing Innovation Centre

CPI

SEAMUS RYAN

Head of Supply Chain and Project Management

SK biotek

JIM FOX

VP & Site Director, PSC Ware Site

GlaxoSmithKline

RACHEL MURPHY

Chief Executive Officer

Difrent

MARK BUSWELL

Vice President, Vaccines Tech

GSK

TREVOR JONES CBE

Director

Arix Bioscience plc and e-Therapeutics plc

RICHARD TORBETT

Chief Executive Officer

ABPI

PRIYA MANDE

Chief Operating Officer

PsiOxus Therapeutics

HASSAN CHAUDHURY

Digital Health Specialist | Healthcare UK

Department for International Trade

JO PISANI

Strategic Advisor, Non Executive Director and Charity Trustee

KIMBERLY SMITH

Senior Vice President, Head of Research & Development

ViiV Healthcare

SCOTT JOHNSTONE

Chief Executive Officer

Scottish Lifesciences Association

CHRISTIAN JONES

Chief Commercial Officer

Nanoform

STEFAN SUTER

Head Europe

Holmusk

FLIC GABBAY

Managing Partner

tranScrip

MIKE REA

Strategic Innovation Advisor and Chief Executive Officer

Nanoform and IDEA Pharma

MARK MILTON-EDWARDS

Head of Health Solutions – Digital Health

TEVA Pharmaceuticals

JASON LACOMBE

Chief Executive Officer

Veratrak

JOYDEEP SARKAR

Chief Analytics Officer

Holmusk

AMANDA SIMONS

Partner, Patent Attorney

J A Kemp LLP

DETLEF BEHRENS

Managing Director

Bay Pharma

JOE DE SOUSA

Senior Leader, Non-Exec Director and Independent Consultant

Melhor Consulting

KATHRYN SIMPSON

Business Consultant

Kathryn Simpson Consulting

VANESSA LEMARIE

Director of Business Development Life Sciences & Program Owner of Rare Disease Initiative

Ada Health

MARK DUMAN

Chief Patient Officer

MD Healthcare Consultants

ANDREW CARMODY

Chief Executive Officer

The Health Data Exchange

HELEN BARKER

Head of Pharmaceutical Development

Reneo Pharma

ALASTAIR FLORENCE

Director, Continuous Manufacturing and Advanced Crystallisation (CMAC) Research Hub

University of Strathclyde

ASHLEY HOWARD

EMEA Manager, APG Pharma Solutions

Applied Materials 

ROMA MAGUIRE

Professor of Digital Health and Care

University of Strathclyde

JAGJIT SINGH SRAI

Head, Centre for International Manufacturing, Institute for Manufacturing

University of Cambridge

GEORGE CROOKS

Chief Executive Officer

Digital Health & Care Institute

STUART NEEDLEMAN

Chief Commercial Officer

Piramal Pharma Solutions

SEAN BREEN

Head Public Private Partnerships and Science Policy

Takeda

STEVE ANDERSON

Chief Scientific Officer

Covance Drug Development

MICHELE LESUEUR

Business Unit Director, UK & Ireland

Bristol Myers Squibb

NICK SIREAU

Chair and Chief Executive Officer

AKU Society

DAVID HAWKINS

Founder and Chief Executive Officer

Remedium Capital

PAUL TUNNAH

Founder and Chief Content Officer

pharmaphorum and Healthware Group

MIKE GIBSON

Chief Technical Officer

Sterling Pharma Solutions

TINA FLATAU

Chief Executive Officer

Biopharma Projects

NATALIA NOVAC

Senior Director, Emerging Technology & Innovation, Corporate Business Development

Eli Lilly

GLENN CROCKER

Head of Life Sciences & Chairman

JLL & BioCity Group

NICOLE MATHER

Executive Partner, Life Sciences Lead 

IBM Services

PATRICK SHORT

Co-founder and Chief Executive Officer

Sano Genetics

GERALDINE VENTHOYE

Chief Scientific Officer & Executive Vice President – Product Development

Vectura

STEVE FORD

Chief Executive

Parkinson’s UK

HASSAN MUMTAZ

Senior Manager (Application)

Applied Materials

TIM LUKER

Vice President Emerging Technology and Innovation

Eli Lilly

ALEX ROBERTSON

Senior Director, Global Clinical Supply Chain

AstraZeneca

EMMA PALMER FOSTER

Healthcare Consultant, Corporate & Financial Strategy | IR | Communications

EJ Palmer Consulting

RICHARD WEAVER

Founder and Managing Director

XenoGesis

CLIVE DIX

Chief Executive Officer

C4X Discovery

DAVID HARRISON

Senior Director, External Manufacturing and Partnering

UCB

Chief Executive Officer

JAN THIRKETTLE

Chief Development Officer

Freeline

DOMINIC BRITTAIN

Senior Global Program Head, Global Drug Development, Respiratory

Novartis

ROSS BURN

Chief Executive Officer

CatSci and Capital Drug Development

ROB HARRIS

Director

Beyond Quality

NICK JOHNSON

Chief Strategy Officer

Cell and Gene Therapy Catapult

PATRICK HYETT

Pharma Supply Chain Tech Digital Innovation Lead

GlaxoSmithKline

CRAIG GRANT

Global Director, Solid Form & Particle Engineering

Johnson Matthey

JOHN DRAKENBERG RENANDER

Co-founder & CEO

Alex Therapeutics

KAROLINA NIEWOLA

Business Development and Strategic Alliances

iOnctura SA

KATIE MURRAY

Technical Director at MMIC

CPI

ERIC DE VOS

VP of Global Innovation & Director of R&D Europe

Ajinomoto Bio-Pharma Services

TASMINA GORAYA

Partner, IP and Life Sciences Regulatory

Taylor Wessing

JOHN McDERMOTT

Executive Drug Development Consultant

Quotient Sciences

KONRAD DOBSCHUETZ

Head of Customer Solutions, (Digital) Health Innovation and BIOME Lead UK

Novartis

NEIL JONES

Director Business Development, Europe,

Catalent